Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials
Hamzah Bakouni(Centre Hospitalier de l’Université de Montréal), Didier Jutras‐Aswad(Centre Hospitalier de l’Université de Montréal), Arash Bahremand(Université Laval), Sarah Drouin(Sorbonne Université), Nadine Ezard(Alcohol and Drug Foundation), Daniela Ziegler(Université de Montréal), Krista J. Siefried(St Vincent's Hospital Melbourne), Bernard Le Foll(Centre for Addiction and Mental Health), Heidar Sharafi(Centre Hospitalier de l’Université de Montréal), Paxton Bach(University of British Columbia), Christian G. Schütz(University of British Columbia), Vítor S. Tardelli(Universidade Federal de São Paulo)
Cited by 22
Related Papers
Genetics of dopamine receptors and drug addiction: a comprehensive review
|Behavioural Pharmacology|2009|396
Tobacco and nicotine use
|Nature Reviews Disease Primers|2022|293
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States
|Applied and Environmental Microbiology|2006|238
Identification of Dopamine D1–D3 Receptor Heteromers
|Journal of Biological Chemistry|2008|230
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
|Journal of General Internal Medicine|2019|150